D020845Chemicals & DrugsD06.347.360.827D27.505.696.399.450.360.827511450.878231Selective Estrogen Receptor ModulatorsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonBreast Medical OncologyClinical Cancer PreventionMD AndersonTHERESE BARTHOLOMEWBEVERSTHERESE BARTHOLOMEW BEVERS8710BEVERS, THERESE BARTHOLOMEWProfessor74Professor10Assistant Professor6Adjunct Professor47Distinguished Service ProfessorVIRGIL CRAIGJORDANVIRGIL CRAIG JORDAN11914JORDAN, VIRGIL CRAIGProfessorPHILIPPMAXIMOVPHILIPP MAXIMOV11918MAXIMOV, PHILIPPAssistant Professor29174957Lo EM, Rodriguez KM, Pastuszak AW, Khera MSexual medicine reviewsAlternatives to Testosterone Therapy: A Review. Sex Med Rev. 2018 01; 6(1):106-113.Sex Med Rev2017-11-27T00:00:002017Alternatives to Testosterone Therapy: A Review.29618460Brewster AM, Thomas P, Brown P, Coyne R, Yan Y, Checka C, Middleton L, Do KA, Bevers TCancer prevention research (Philadelphia, Pa.)A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ. Cancer Prev Res (Phila). 2018 05; 11(5):295-302.Cancer Prev Res (Phila)2018-04-04T00:00:002018A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ.5.975090.015263951research area of0.7636330.0573624118subject area forDepartment of Molecular & Cellular BiologyMolecular & Cellular BiologyBaylor College of MedicineDONALDMCDONNELLDONALD MCDONNELL0.000000000000000.000000000000003029MCDONNELL, DONALDAdjunct ProfessorBERTO'MALLEYBERT O'MALLEY0.000000000000000.000000000000002464O'MALLEY, BERTDistinguished Service Professor30911948Jordan VCAnnals of surgical oncologyThe SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture. Ann Surg Oncol. 2019 Jul; 26(7):1981-1990.Ann Surg Oncol2019-03-25T00:00:002019The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture.30987772Gaillard SL, Andreano KJ, Gay LM, Steiner M, Jorgensen MS, Davidson BA, Havrilesky LJ, Alvarez Secord A, Valea FA, Colon-Otero G, Zajchowski DA, Chang CY, McDonnell DP, Berchuck A, Elvin JAGynecologic oncologyConstitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies. Gynecol Oncol. 2019 07; 154(1):199-206.Gynecol Oncol2019-04-13T00:00:002019Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies.true1Distinguished Service ProfessorDistinguished Service Professortrue1Adjunct ProfessorAdjunct Professor32381587Andreano KJ, Baker JG, Park S, Safi R, Artham S, Oesterreich S, Jeselsohn R, Brown M, Sammons S, Wardell SE, Chang CY, Norris JD, McDonnell DPMolecular cancer therapeuticsThe Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor. Mol Cancer Ther. 2020 07; 19(7):1395-1405.Mol Cancer Ther2020-05-07T00:00:002020The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor.true1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor